-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UoBtRnCjGY8gX0OqJ1eexFo4RAyWl9X5dMncB9/3iqhWwxzQheiN9ofKC6K7xLcc ajcF0NKJGniwnDVWIbGWGA== 0000898431-99-000076.txt : 19990420 0000898431-99-000076.hdr.sgml : 19990420 ACCESSION NUMBER: 0000898431-99-000076 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990419 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-42057 FILM NUMBER: 99596497 BUSINESS ADDRESS: STREET 1: 35 W WATKINS MILL RD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3014170770 MAIL ADDRESS: STREET 1: 35 W WATKINS MILL ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: INVESTOR AB CENTRAL INDEX KEY: 0000889232 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: S-10332 CITY: STOCKHOLM SWEDEN STATE: V7 MAIL ADDRESS: STREET 1: KIRKPATRICK & LOCKHART LLP STREET 2: 1500 OLIVER BUILDING CITY: PITTSBURGH STATE: PA ZIP: 15222 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Information Statement Pursuant to Rules 13d-1 and 13d-2 Under the Securities Exchange Act of 1934 MedImmune, Inc. - -------------------------------------------------------------------------------- (NAME OF ISSUER) Common Stock, par value $.01 per share - -------------------------------------------------------------------------------- (TITLE OF CLASS OF SECURITIES) 584699-10-2 - -------------------------------------------------------------------------------- (CUSIP NUMBER) April 16, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of their Statement) ------------------------------- Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ X ] Rule 13d-1(c) [ ] Rule 13d-1(d) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ------------------------------- Page 1 of 6 Pages SCHEDULE 13G - --------------------------- CUSIP No. 584699-10-2 - --------------------------- - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: Investor AB S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ---- (b) X ---- - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Kingdom of Sweden - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF SHARES 3,238,000 BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ------------------------------------------------------------------- SHARED VOTING POWER 6 ------------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 3,238,000 ------------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 3,238,000 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES --- - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.9% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- Page 2 of 6 Pages This Statement on Schedule 13G is being filed solely for the purpose of converting the Statement on Schedule 13D filed on February 2, 1998 (the "Schedule 13D") into a Schedule 13G for a Passive Investor under Rule 13d-1(c), as amended by Securities and Exchange Release No. 34-39538. ITEM 1. (a) Name of Issuer: MedImmune, Inc. (b) Address of Issuer's Principal Executive Offices: 35 West Watkins Mill Road, Gaithersburg, Maryland 20878 ITEM 2. (a) Name, Address and Citizenship of Filing Person: Investor AB ("Investor AB"), a publicly-held Swedish corporation, whose address is S-103 32, Stockholm, Sweden, and which is engaged in the business of the long-term holding of equity securities. (b) Title of Class of Securities: Common Stock (c) CUSIP Number: 584699-10-2 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13(D)-1(B) OR 13D-2(B): Not applicable Page 3 of 6 Pages ITEM 4. OWNERSHIP (a) Investor AB has record and beneficial ownership of an aggregate of 3,238,000 shares. (b) The 3,238,000 shares beneficially owned by Investor AB are 5.9% of the outstanding Common Stock, based upon the number of shares of Common Stock outstanding at December 31, 1998, as reported by the issuer in its Annual Report on Form 10-K for the year ended December 31, 1998. As reflected in the Schedule 13D, Investor AB initially obtained beneficial owernship of 1,619,000 shares through (and was deemed to share dispositive power with) subsidiaries that were wholly-owned, directly or indirectly, by Investor AB. Pursuant to a two-for-one stock split of the Common Stock, Investor AB is the beneficial owner of 3,238,000 shares. Since the filing of the Schedule 13D, Investor AB has obtained sole voting and dispositive power over the 3,238,000 shares due to internal restructuring among its subsidiaries. (c) Investor AB, has sole power to vote or to direct the vote, and to dispose or direct the disposition of, the 3,238,000 shares. ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable Page 4 of 6 Pages ITEM 9. NOTICE OF DISSOLUTION OF GROUP Not applicable ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 5 of 6 Pages CUSIP No.: 584699-10-2 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Investor AB By: /s/ Henry Goss ---------------------------- Name: Henry Goss Title: Managing Director Page 6 of 6 Pages -----END PRIVACY-ENHANCED MESSAGE-----